U.S. Food and Drug Administration Grants Priority Review to Harmony Biosciences’ Application for WAKIX® (Pitolisant) in Pediatric Narcolepsy
PLYMOUTH MEETING, Pa., Feb. 21, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) announced that the U.S. Food and...
